News
1h
InvestorsHub on MSNProKidney Shares Dip Following FDA Agreement on Rilparencel Approval StrategyProKidney Corp. (NASDAQ:PROK) saw its stock drop 11% in early trading before recovering somewhat to close down 3%, after ...
The U.S. Food and Drug Administration's staff reviewers on Tuesday raised safety concerns that GSK's blood cancer drug Blenrep, when used in combination with other treatments, may cause eye damage in ...
Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...
The U.S. Food and Drug Administration announced a massive recall of 30 different kinds of produce over possible contamination ...
3d
News Nation on MSNFDA Commissioner: ‘We want to focus on food’“We want to focus on food. People forget that the ‘F’ in FDA stands for food,” Makary said. Makary noted that the processed ...
It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually ...
On July 10, 2025, the Food and Drug Administration (FDA) announced that it had published more than 200 complete response letters (CRLs), in ...
FDA head Marty Makary said the agency may fast-track drugs from companies that “equalize” the cost of medicines between the U ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results